Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 27, 2023 07:30 ET | Source: SIGA Technologies Inc.

SIGA Technologies to Host Business Update Call on May 4th, 2023 Following Release of First Quarter 2023 Financial Results

NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...
March 02, 2023 16:05 ET | Source: SIGA Technologies Inc.

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2022

- Approximately $71 Million of International Product Sales in 2022 - - Corporate Update Conference Call Today at 4:30 PM ET - NEW YORK, March 02, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc....
February 23, 2023 07:30 ET | Source: SIGA Technologies Inc.

SIGA Technologies to Host Business Update Call on March 2nd, 2023 Following Release of Fourth Quarter and Full Year 2022 Financial Results

NEW YORK, Feb. 23, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...
January 17, 2023 07:30 ET | Source: SIGA Technologies Inc.

SIGA Technologies Announces Planned Retirement of CEO Phil Gomez in 2023

NEW YORK, Jan. 17, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Phil...
November 03, 2022 16:05 ET | Source: SIGA Technologies Inc.

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2022

- Approximately $61 Million of International Sales in the Third Quarter – - Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies,...
October 27, 2022 16:15 ET | Source: SIGA Technologies Inc.

SIGA Technologies to Host Business Update Call on November 3rd, 2022 Following Release of Third Quarter 2022 Financial Results

NEW YORK, Oct. 27, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...
October 12, 2022 16:05 ET | Source: SIGA Technologies Inc.

SIGA Provides Update on Progress in Clinical Trials to Assess Use of TPOXX ® (tecovirimat) for Treatment of Monkeypox

Trials are currently underway in the United States, United Kingdom and Democratic Republic of CongoPending positive results from clinical trials, SIGA plans to file with U.S. regulators for regulatory...
September 29, 2022 07:30 ET | Source: SIGA Technologies Inc.

SIGA Technologies Announces New Contract Awarded by U.S. Department of Defense for the Procurement of up to $10.7 Million of Oral TPOXX®

NEW YORK, Sept. 29, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the...
September 26, 2022 10:07 ET | Source: SIGA Technologies Inc.

SIGA Announces Approximately $16 Million of International Procurement Orders Received in August and Early September for Oral TPOXX® (Tecovirimat)

- Order for Approximately $10 Million Funded by the European Commission – - Orders for Approximately $6 Million Received from Two Countries in the Asia Pacific Region - NEW YORK, Sept. 26,...
August 09, 2022 07:30 ET | Source: SIGA Technologies Inc.

SIGA Announces BARDA Exercise of Procurement Options Valued at Approximately $26 Million for IV TPOXX®

- IV TPOXX is an Important Option for Those Unable to Swallow – - Option to Fund Post-Marketing Field Study for IV TPOXX also Exercised – NEW YORK, Aug. 09, 2022 (GLOBE NEWSWIRE) -- SIGA...